{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T15:51:12Z","timestamp":1783525872675,"version":"3.55.0"},"reference-count":23,"publisher":"American Academy of Pediatrics (AAP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1997,10,1]]},"abstract":"<jats:p>Objective.\u2003To compare the side effect profiles of methylphenidate (MPH) and dexamphetamine (DEX) in children with attention deficit hyperactivity disorder (ADHD), as well as to determine which symptoms are genuine adverse effects of stimulant medication, as opposed to aspects of the child's underlying behavioral phenotype.<\/jats:p><jats:p>Design.\u2003Double-blind, crossover study.<\/jats:p><jats:p>Setting.\u2003Pediatric teaching hospital ambulatory behavior clinic.<\/jats:p><jats:p>Subjects.\u2003A total of 125 children with ADHD with a mean age of 104.8 months.<\/jats:p><jats:p>Interventions.\u2003Subjects received DEX (0.15 mg\/kg\/dose) and MPH (0.3 mg\/kg\/dose) twice a day for 2 weeks each in a randomized order.<\/jats:p><jats:p>Outcome Measures.\u2003The Barkley Side Effects Rating Scale (17 symptoms; 0 = absent, severity rated from 1 to 9) was completed by parents at baseline and at the completion of each trial fortnight.<\/jats:p><jats:p>Results.\u2003Subjects' parents reported a significantly greater mean number (8.19) and mean severity (4.08) of \u201cside effects\u201d before commencing the trial than during the MPH period (number 7.19; severity 3.24), but not the DEX period (number 7.64, severity 3.73). The mean severity (but not mean number) was greater on DEX than on MPH. DEX caused more severe insomnia and appetite suppression compared with the baseline rating. Appetite suppression was the only item rated more severe on MPH than at baseline. Six side effects were significantly more severe on DEX than MPH: insomnia, irritability, proneness to crying, anxiousness, sadness\/unhappiness, and nightmares. None were more severe on MPH than DEX. Overall, both MPH and DEX were well tolerated by most subjects, with only four subjects discontinuing the trial period because of severe adverse effects (2 [1.6%] on each stimulant).<\/jats:p><jats:p>Conclusions.\u2003Many symptoms commonly attributed to stimulant medication are actually preexisting characteristics of children with ADHD and improve with stimulant treatment. At the doses investigated, both DEX and MPH caused appetite suppression, and DEX caused insomnia. Negative emotional symptoms were more severe on DEX than MPH.<\/jats:p>","DOI":"10.1542\/peds.100.4.662","type":"journal-article","created":{"date-parts":[[2004,8,13]],"date-time":"2004-08-13T23:40:17Z","timestamp":1092440417000},"page":"662-666","source":"Crossref","is-referenced-by-count":232,"title":["Side Effects of Methylphenidate and Dexamphetamine in Children With Attention Deficit Hyperactivity Disorder: A Double-blind, Crossover Trial"],"prefix":"10.1542","volume":"100","author":[{"given":"Daryl","family":"Efron","sequence":"first","affiliation":[{"name":"1From the Centre for Community Child Health and Ambulatory Paediatrics, Royal Children's Hospital, Melbourne, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick","family":"Jarman","sequence":"additional","affiliation":[{"name":"1From the Centre for Community Child Health and Ambulatory Paediatrics, Royal Children's Hospital, Melbourne, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melinda","family":"Barker","sequence":"additional","affiliation":[{"name":"1From the Centre for Community Child Health and Ambulatory Paediatrics, Royal Children's Hospital, Melbourne, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[1997,10,1]]},"reference":[{"key":"2021120904411094000_B1","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1176\/ajp.94.3.577","article-title":"The behavior of children receiving benzedrine.","volume":"94","author":"Bradley","year":"1937","journal-title":"Am J Psychiatry."},{"key":"2021120904411094000_B2","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1469-7610.1977.tb00425.x","article-title":"A review of stimulant drug research with hyperactive children.","volume":"18","author":"Barkley","year":"1977","journal-title":"J Child Psychol Psychiatry."},{"key":"2021120904411094000_B3"},{"key":"2021120904411094000_B4","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0165-1781(91)90126-A","article-title":"Methylphenidate and dextroamphetamine treatments of hyperactivity: are there true nonresponders?","volume":"36","author":"Elia","year":"1991","journal-title":"Psychiatry Res."},{"key":"2021120904411094000_B5"},{"key":"2021120904411094000_B6"},{"key":"2021120904411094000_B7"},{"key":"2021120904411094000_B8","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1126\/science.341313","article-title":"Dextroamphetamine: cognitive and behavioral effects in normal prepubertal boys.","volume":"199","author":"Rapoport","year":"1978","journal-title":"Science."},{"key":"2021120904411094000_B9","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1542\/peds.86.2.184","article-title":"Side effects of methylphenidate in children with attention deficit hyperactivity disorder: a systemic, placebo-controlled evaluation.","volume":"86","author":"Barkley","year":"1990","journal-title":"Pediatrics."},{"key":"2021120904411094000_B10","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1542\/peds.91.6.1101","article-title":"Placebo-controlled evaluation of Ritalin side effects.","volume":"91","author":"Ahmann","year":"1993","journal-title":"Pediatrics."},{"key":"2021120904411094000_B11","first-page":"670","article-title":"The response of aggressive and nonaggressive ADHD children to two doses of methylphenidate. J Am Acad Child Adolesc Psychiatry. 1989;28:873\u2013881. Erratum.","volume":"29","author":"Barkley","year":"1990","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"2021120904411094000_B12","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1542\/peds.53.2.236","article-title":"Dextroamphetamine and methylphenidate in the treatment of hyperactive\/aggressive children.","volume":"53","author":"Winsberg","year":"1974","journal-title":"Pediatrics."},{"key":"2021120904411094000_B13","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1177\/002221947100400904","article-title":"Recent drug studies with hyperkinetic children.","volume":"4","author":"Conners","year":"1971","journal-title":"J Learn Disabil."},{"key":"2021120904411094000_B14"},{"key":"2021120904411094000_B15"},{"key":"2021120904411094000_B16"},{"key":"2021120904411094000_B17"},{"key":"2021120904411094000_B18"},{"key":"2021120904411094000_B19","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/BF00919127","article-title":"Normative data on revised Conners parent and teacher rating scales.","volume":"6","author":"Goyette","year":"1978","journal-title":"J Abnorm Child Psychol."},{"key":"2021120904411094000_B20","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/BF00917077","article-title":"The computerized continuous performance task: a new measure of inattention.","volume":"11","author":"Klee","year":"1983","journal-title":"J Abnorm Child Psychol."},{"key":"2021120904411094000_B21","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0031-3955(16)32054-5","article-title":"Treatment of minimal brain dysfunction syndromes.","volume":"14","author":"Millichap","year":"1967","journal-title":"Pediatr Clin North Am."},{"key":"2021120904411094000_B22","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1542\/peds.49.5.702","article-title":"Psychological effects of stimulant drugs in children with minimal brain dysfunction.","volume":"49","author":"Conners","year":"1972","journal-title":"Pediatrics."},{"key":"2021120904411094000_B23","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1542\/peds.86.2.226","article-title":"Relative efficacy of long-acting stimulants on children with attention deficit-hyperactivity disorder: a comparison of standard methylphenidate, sustained-release methylphenidate, sustained-release dextroamphetamine, and pemoline.","volume":"86","author":"Pelham","year":"1990","journal-title":"Pediatrics."}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/100\/4\/662\/889455\/pe109700662o.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/100\/4\/662\/889455\/pe109700662o.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,14]],"date-time":"2024-01-14T05:04:47Z","timestamp":1705208687000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/100\/4\/662\/52173\/Side-Effects-of-Methylphenidate-and-Dexamphetamine"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,10,1]]},"references-count":23,"journal-issue":{"issue":"4","published-online":{"date-parts":[[1997,10,1]]},"published-print":{"date-parts":[[1997,10,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.100.4.662","relation":{},"ISSN":["1098-4275","0031-4005"],"issn-type":[{"value":"1098-4275","type":"electronic"},{"value":"0031-4005","type":"print"}],"subject":[],"published":{"date-parts":[[1997,10,1]]}}}